StockData
BLCONYSEOphthalmic GoodsFiscal year ends December 31

Bausch & Lomb Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$16.61+0.12 (+0.73%)

Close on Oct 19, 2026

Market cap
$5.93B
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Oct 28, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 29, 2026Before market open$1.39B$-0.04$0.15
Q1 FY2026
Ended Mar 31, 2026
Apr 29, 2026Before market open$1.24B$-0.20$0.05
Q4 FY2025
Ended Dec 31, 2025
Feb 18, 2026Before market open$1.41B$-0.16$0.32
Q3 FY2025
Ended Sep 30, 2025
Oct 29, 2025Before market open$1.28B$-0.08$0.18
Q2 FY2025
Ended Jun 30, 2025
Jul 30, 2025Before market open$1.28B$-0.18$0.07
Q1 FY2025
Ended Mar 31, 2025
Apr 30, 2025Before market open$1.14B$-0.60$-0.15
Q4 FY2024
Ended Dec 31, 2024
Feb 19, 2025Before market open$1.28B$-0.01$0.25
Q3 FY2024
Ended Sep 30, 2024
Oct 30, 2024Before market open$1.20B$0.01$0.13
Q2 FY2024
Ended Jun 30, 2024
Jul 31, 2024Before market open–––
Q1 FY2024
Ended Mar 31, 2024
May 1, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Feb 21, 2024Before market open–––

Company guidance

Outlook given with results on Jul 29, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Full-Year Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)non-GAAPFull-Year$1.03B to $1.08BRaised
constant currency growthnon-GAAPFull-Year5.8% to 7.7% growthRaised
Full-Year RevenueGAAPFull-Year$5.44B to $5.54BRaised

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Bausch & Lomb filed with the SEC